title: Drug delivery to the inner ear: strategies and their therapeutic implications for sensorineural hearing loss.
abstract: Hearing aids or cochlear implants constitute almost exclusively the treatment options currently available to patients suffering from sensorineural hearing loss and related conditions, such as noise-induced hearing loss, ototoxicity or autoimmune inner ear disease. While some systemic treatments exist, they generally exert adverse secondary effects and their efficacy is hampered by the blood-cochlear barrier that limits drug access to the inner ear. Hence, the new therapies that are being developed for hearing loss focus on strategies for direct drug delivery to the inner ear. The passive and active methods for local delivery can be categorized into two general groups: intratympanic or intracochlear. The intratympanic approach is a non-invasive method that preserves hearing and takes advantage of the permeability of the round window to gain access to the cochlea. However, this technique is limited by not knowing the dose of the drug that reaches the cochlea, (a handicap which might be overcome by the use of tagged drugs). While direct access to the inner ear by intracochlear administration avoids this problem, this method requires surgery. Currently, laboratory animals are being used to explore which therapeutic approaches are best suited to address this problem. These include cochleostomy and the insertion of devices that pump drugs into the inner ear without inducing cochlear damage. In this article, we review the different techniques under evaluation in animal models of deafness, and their potential use for drug delivery and treatment of human inner ear diseases.
authors.affiliation: University Hospital Prince of Asturias, University of Alcalá, Madrid, Spain. trivera.hupa@salud.madrid.org
authors.forename: Teresa
authors.initials: T
authors.lastname: Rivera
authors.forename: Lorena
authors.initials: L
authors.lastname: Sanz
authors.forename: Guadalupe
authors.initials: G
authors.lastname: Camarero
authors.forename: Isabel
authors.initials: I
authors.lastname: Varela-Nieto
mesh_terms: D000818:Animals; D016503:Drug Delivery Systems; D007758:Ear, Inner / Q000378:metabolism*; D006319:Hearing Loss, Sensorineural / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D004364:Pharmaceutical Preparations / Q000008:administration & dosage
chemical_list: D004364:Pharmaceutical Preparations